VSEE VSEE HEALTH, INC.
Services-Health Services · OTC · SEC CIK 1864531 · Fiscal year ends 12/31
Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY9.0%
TTM net income YoY81.1%
TTM EPS YoY96.1%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin42.1%
Operating margin-88.4%
Net margin-98.9%
FCF margin-50.8%
EBITDA margin-68.0%
Returns
ROE-1,345.0%
ROA-71.5%
ROIC (approx.)-412.2%
Asset turnover0.72x
Leverage & solvency
Liabilities / assets54.6%
Debt / equity0.15x
Current ratio0.40x
Interest coverage-5.69x
Cash quality & payout
Operating cash flow / net income0.51x
Accruals ratio-35.4%
Payout ratio—
Capex / revenue0.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $14.62M | $10.42M | $5.77M | — |
| Cost of revenue | $7.26M | $3.24M | $1.93M | — |
| Gross profit | $7.36M | $7.18M | $3.83M | — |
| SG&A expense | $10.04M | $6.55M | $1.20M | — |
| Operating income | -$9.58M | -$62.15M | -$1.87M | -$3.59M |
| Interest expense | $2.81M | $211,459 | $191,323 | $125,980 |
| Pretax income | -$14.64M | -$59.34M | -$1.89M | -$3.06M |
| Income tax | $68,426 | -$1.64M | $1.84M | $187,225 |
| Net income | -$14.71M | -$57.70M | -$3.76M | -$3.24M |
| EBITDA | -$7.00M | -$60.83M | -$1.87M | — |
| EPS (basic) | -0.73 | -5.65 | -0.38 | -0.25 |
| EPS (diluted) | -0.73 | -5.65 | -0.38 | -0.25 |
| Weighted avg. shares (diluted) | 20.14M | 10.21M | 10.00M | 12.74M |
| Balance sheet | ||||
| Cash & equivalents | $5.05M | $326,115 | $118,734 | $230,664 |
| Receivables | $2.24M | $1.72M | $603,480 | — |
| Current assets | $8.37M | $3.02M | $802,134 | $106,998 |
| PP&E, net | $294,987 | $680,242 | $3,657 | — |
| Goodwill | $4.92M | $4.92M | — | — |
| Intangibles | $8.79M | $10.99M | $0 | — |
| Total assets | $22.41M | $19.99M | $805,791 | $7.63M |
| Current liabilities | $16.24M | $19.01M | $5.11M | $3.30M |
| Short-term debt | $880,175 | $433,983 | $220,000 | — |
| Long-term debt | $593,941 | $593,941 | $220,000 | — |
| Total debt | $1.47M | $1.03M | $440,000 | — |
| Total liabilities | $16.96M | $20.01M | $5.11M | $7.67M |
| Shareholders' equity | $5.45M | -$18,488 | -$12.27M | -$7.43M |
| Net debt | -$3.58M | $701,809 | $321,266 | — |
| Shares outstanding | 33.19M | 16.30M | 4.64M | — |
| Cash flow statement | ||||
| Operating cash flow | -$3.45M | -$5.79M | -$632,595 | -$1.39M |
| Capital expenditure | $29,928 | $55,267 | $4,335 | — |
| Free cash flow | -$3.48M | -$5.84M | -$636,930 | — |
| Investing cash flow | -$29,928 | -$26,144 | -$4,335 | $110.12M |
| Financing cash flow | $8.42M | $6.02M | $525,000 | -$109.38M |
| Depreciation & amortization | $2.59M | $1.32M | $678 | — |
| Stock-based compensation | $1.12M | $896,537 | $0 | — |
| Share buybacks | $44 | $5,150 | $6.80M | $110.47M |
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.